sarcosine has been researched along with Brain Diseases in 2 studies
cocobetaine: N-alkyl-betaine; cause of shampoo dermatitis
Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Compelling animal and clinical studies support the N-methyl-D-aspartate receptor (NMDAR) hypofunction hypothesis of schizophrenia and suggest promising pharmacological agents to ameliorate negative and cognitive symptoms of schizophrenia, including sarcosine, a glycine transporter-1 inhibitor." | 7.91 | Therapeutic potential and underlying mechanism of sarcosine (N-methylglycine) in N-methyl-D-aspartate (NMDA) receptor hypofunction models of schizophrenia. ( Hung, WL; Lai, WS; Lin, BX; Lu, LY; Luo, DZ; Min, MY; Pei, JC; Shih, MH; Studer, V; Tai, HC, 2019) |
| "Compelling animal and clinical studies support the N-methyl-D-aspartate receptor (NMDAR) hypofunction hypothesis of schizophrenia and suggest promising pharmacological agents to ameliorate negative and cognitive symptoms of schizophrenia, including sarcosine, a glycine transporter-1 inhibitor." | 3.91 | Therapeutic potential and underlying mechanism of sarcosine (N-methylglycine) in N-methyl-D-aspartate (NMDA) receptor hypofunction models of schizophrenia. ( Hung, WL; Lai, WS; Lin, BX; Lu, LY; Luo, DZ; Min, MY; Pei, JC; Shih, MH; Studer, V; Tai, HC, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pei, JC | 1 |
| Hung, WL | 1 |
| Lin, BX | 1 |
| Shih, MH | 1 |
| Lu, LY | 1 |
| Luo, DZ | 1 |
| Tai, HC | 1 |
| Studer, V | 1 |
| Min, MY | 1 |
| Lai, WS | 1 |
| Küpfer, A | 1 |
| Aeschlimann, C | 1 |
| Wermuth, B | 1 |
| Cerny, T | 1 |
2 other studies available for sarcosine and Brain Diseases
| Article | Year |
|---|---|
Therapeutic potential and underlying mechanism of sarcosine (N-methylglycine) in N-methyl-D-aspartate (NMDA) receptor hypofunction models of schizophrenia.
Topics: Animals; Behavioral Symptoms; Brain Diseases; Disease Models, Animal; Dizocilpine Maleate; Excitator | 2019 |
Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue.
Topics: Administration, Oral; Adolescent; Antidotes; Bone Neoplasms; Brain Diseases; Drug Overdose; Female; | 1994 |